Biological agents versus chemotherapy in the treatment of colorectal cancer.

about

Study on the mitochondrial apoptosis pathways of small cell lung cancer H446 cells induced by Trichinella spiralis muscle larvae ESPs.Radiofrequency ablation with systemic chemotherapy in the treatment of colorectal cancer liver metastasis: a 10-year single-center study

P2860

Q50959584-AF6E2C6F-F079-4503-BB56-915951E8AA29 Q59125982-BC8A8327-A6F2-4DD1-85C4-9F716AFAB53B

P2860

Biological agents versus chemotherapy in the treatment of colorectal cancer.

Item

http://www.wikidata.org/entity/Q36521850

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Biological agents versus chemotherapy in the treatment of colorectal cancer.

@ast

Biological agents versus chemotherapy in the treatment of colorectal cancer.

@en

type

Item

label

Biological agents versus chemotherapy in the treatment of colorectal cancer.

@ast

Biological agents versus chemotherapy in the treatment of colorectal cancer.

@en

prefLabel

Biological agents versus chemotherapy in the treatment of colorectal cancer.

@ast

Biological agents versus chemotherapy in the treatment of colorectal cancer.

@en

P1476

Biological agents versus chemotherapy in the treatment of colorectal cancer.

@en

P2093

Cathy Eng

http://www.w3.org/2001/XMLSchema#string

Nabeel Shalan

http://www.w3.org/2001/XMLSchema#string

P2860

Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface

pp60c-src activation in human colon carcinoma

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer

P304

1251-1271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.7.10.1251

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16805714

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

chemotherapy

Biological agents versus chemotherapy in the treatment of colorectal cancer.

about

P2860

P2860

Biological agents versus chemotherapy in the treatment of colorectal cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921